Clyde W. Shearman
- Molecular Biology
- Clinical Biochemistry top 1%
- Nephrology top 2%
- Endocrinology, Diabetes and Metabolism top 5%
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Margo P. CohenLawrence A. LoebGregory T. LautenslagerSheldon ChenElizabeth SheaFuad N. ZiyadehElizabeth HudJonathan Cohen
- Topics
- Advanced Glycation End Products research (16 papers)Chronic Kidney Disease and Diabetes (15 papers)DNA Repair Mechanisms (7 papers)
- Partner nations
- United StatesGermanyIsrael
In The Last Decade
Clyde W. Shearman
40 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 92
- Molecular Biology 564
- Clinical Biochemistry 371
- Nephrology 287
- Endocrinology, Diabetes and Metabolism 241
- Radiology, Nuclear Medicine and Imaging 180
Countries citing papers authored by Clyde W. Shearman
This map shows the geographic impact of Clyde W. Shearman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clyde W. Shearman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clyde W. Shearman more than expected).
Fields of papers citing papers by Clyde W. Shearman
This network shows the impact of papers produced by Clyde W. Shearman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clyde W. Shearman. The network helps show where Clyde W. Shearman may publish in the future.
Co-authorship network of co-authors of Clyde W. Shearman
This figure shows the co-authorship network connecting the top 25 collaborators of Clyde W. Shearman. A scholar is included among the top collaborators of Clyde W. Shearman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clyde W. Shearman. Clyde W. Shearman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 1 | |
| 3 | 20 | |
| 4 | 61 | |
| 5 | 102 | |
| 6 | 13 | |
| 7 | 29 | |
| 8 | 96 | |
| 9 | 22 | |
| 10 | 18 | |
| 11 | 60 | |
| 12 | 45 | |
| 13 | 19 | |
| 14 | 4 | |
| 15 | 9 | |
| 16 | 15 | |
| 17 | Human lymphocyte and monocyte lysis of tumor cells mediated by a mouse/human IgG1 chimeric monoclonal antibody. | 7 |
| 18 | 7 | |
| 19 | Effects of arsenic, selenium, and chromium on the fidelity of DNA synthesis. | 58 |
| 20 | 5 |
About Clyde W. Shearman
Clyde W. Shearman is a scholar working on Clinical Biochemistry, Nephrology and Endocrinology, Diabetes and Metabolism, having authored 40 papers that have together received 1.3k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (16 papers), Chronic Kidney Disease and Diabetes (15 papers) and DNA Repair Mechanisms (7 papers). The work is most often cited by research in Clinical Biochemistry (371 citations), Nephrology (287 citations) and Endocrinology, Diabetes and Metabolism (241 citations). Clyde W. Shearman has collaborated with scholars based in United States, Germany and Israel. Frequent co-authors include Margo P. Cohen, Lawrence A. Loeb, Gregory T. Lautenslager, Sheldon Chen, Elizabeth Shea, Fuad N. Ziyadeh, Elizabeth Hud, Jonathan Cohen, John Ghrayeb and Peter E. Daddona. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.